HUM241108P270000
- 19.65
- 0.000.00%
Humana Newsroom
Humana Is Maintained at Overweight by Wells Fargo
Humana Analyst Ratings
Wells Fargo Maintains Humana(HUM.US) With Buy Rating, Cuts Target Price to $290
Wells Fargo Sticks to Its Buy Rating for Humana (HUM)
TD Cowen Maintains Humana(HUM.US) With Hold Rating, Raises Target Price to $268
Truist Financial Maintains Humana(HUM.US) With Hold Rating
Oppenheimer Maintains Humana(HUM.US) With Buy Rating, Raises Target Price to $300
Humana Analyst Ratings
Barclays Maintains Equal-Weight on Humana, Raises Price Target to $253
Morgan Stanley Maintains Humana(HUM.US) With Hold Rating, Maintains Target Price $288
A Quick Look at Today's Ratings for Humana(HUM.US), With a Forecast Between $247 to $387
RBC Adjusts Price Target on Humana to $283 From $265
Stephens Raises Humana's Price Target to $260 From $250
Morgan Stanley Maintains Humana(HUM.US) With Hold Rating, Maintains Target Price $374
Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Humana (HUM)
Cognizant's Revenue Uncertainty Amid Potential Humana-Cigna Merger Justifies Hold Rating
Baird Maintains Humana(HUM.US) With Hold Rating, Maintains Target Price $374
Hold Rating on Humana Amid Potential MLR Pressures and Strategic Mitigations
Mizuho Securities Cuts Humana's Price Target to $305 From $410
Humana Is Maintained at Hold by Truist Securities